Stéphanie Michaud

Dr. Stéphanie Michaud is the president and CEO of BioCanRx. She has more than 20 years of public, government and private sector experience in research and science & technology innovation policy and is a member of the Board of Directors of Research Canada.

Immunotherapy a beacon of hope in Canada’s fight against cancer

The gap between treatment and cure underscores the dire need for innovative approaches in our health-care strategy.

opinion | BY STéPHANIE MICHAUD | June 5, 2024

It’s time to use the C word: cure

With more than 233,900 cancer diagnoses and 85,100 cancer deaths expected in 2022, more must be done to move the needle for Canadian cancer patients.

opinion | BY STéPHANIE MICHAUD | February 6, 2023